CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Minoxidil

米诺地尔 杂质对照品Minoxidil Impurities

EP27 个杂质条目27 impurity entries

本页汇总 米诺地尔 的 27 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 27 impurity reference standards of Minoxidil with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 米诺地尔(Minoxidil)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA method for the determination of minoxidil in hair-regrowth formulations by micellar electrokinetic capillary chromatography
    Farmaco (Societa chimica italiana : 1989) · 2005 · Gibson G et al.  ·  PMID 16043173  ·  DOI
  2. 杂质研究Impurity studiesExploring the Physicochemical Compatibility of Minoxidil in Combination with Different Active Pharmaceutical Ingredients in Ready-to-use Vehicles for Alopecia Treatment
    Current drug delivery · 2025 · Marianni B et al.  ·  PMID 39844416  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of a procedure for the determination of minoxidil in hair-regrowth formulations using two variants of capillary zone electrophoresis
    Farmaco (Societa chimica italiana : 1989) · 2005 · Patterson SC et al.  ·  PMID 15922339  ·  DOI
  4. 分析方法Analytical MethodsStability indicating RP-HPLC method development and validation for the simultaneous determination of aminexil and minoxidil in pharmaceutical dosage form
    Annales pharmaceutiques francaises · 2015 · Siddiraju S, Sahithi M  ·  PMID 25542653  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisEffect of minoxidil on platelet function and the synthesis of prostaglandins in platelets
    The Journal of laboratory and clinical medicine · 1989 · O'Barr TP et al.  ·  PMID 2553835

米诺地尔 —— 原料药与杂质对照品Minoxidil — drug substance & impurities

共 28 个条目(含原料药本体)28 items incl. the drug substance
Minoxidil structure
EP原料药 APIAPI
米诺地尔Minoxidil
Minoxidil
CAS No.38304-91-5
Chemical FormulaC9H15N5O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 6(Minoxidil EP Impurity A) structure
EPA
米诺地尔杂质6(米诺地尔EP杂质A)Minoxidil Impurity 6(Minoxidil EP Impurity A)
Minoxidil Impurity 6(Minoxidil EP Impurity A)
CAS No.35139-67-4
Chemical FormulaC4H5ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 2(Minoxidil EP Impurity B) structure
EPB
米诺地尔杂质2(米诺地尔EP杂质B)Minoxidil Impurity 2(Minoxidil EP Impurity B)
Minoxidil Impurity 2(Minoxidil EP Impurity B)
CAS No.156-83-2
Chemical FormulaC4H5ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 3(Minoxidil EP Impurity C) structure
EPC
米诺地尔杂质3(米诺地尔EP杂质C)Minoxidil Impurity 3(Minoxidil EP Impurity C)
Minoxidil Impurity 3(Minoxidil EP Impurity C)
CAS No.1798387-81-1
Chemical FormulaC9H14N4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 4(Minoxidil EP Impurity D) structure
EPD
米诺地尔杂质4(米诺地尔EP杂质D)Minoxidil Impurity 4(Minoxidil EP Impurity D)
Minoxidil Impurity 4(Minoxidil EP Impurity D)
CAS No.75105-16-7
Chemical FormulaC11H12N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 5 (Minoxidil EP Impurity E) structure
EPE
米诺地尔杂质5 (米诺地尔EP杂质E)Minoxidil Impurity 5 (Minoxidil EP Impurity E)
Minoxidil Impurity 5 (Minoxidil EP Impurity E)
CAS No.24867-26-3
Chemical FormulaC9H15N5
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Hemisulfate structure
—
半硫酸米诺地尔Minoxidil Hemisulfate
Minoxidil Hemisulfate
CAS No.2127354-04-3
Chemical Formula2(C9H15N5O)·H2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 7 structure
7
米诺地尔杂质7Minoxidil Impurity 7
Minoxidil Impurity 7
CAS No.56828-37-6
Chemical FormulaC9H15N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 8 structure
8
米诺地尔杂质8Minoxidil Impurity 8
Minoxidil Impurity 8
CAS No.74638-76-9
Chemical FormulaC4H6N4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 9 structure
9
米诺地尔杂质9Minoxidil Impurity 9
Minoxidil Impurity 9
CAS No.79459-04-4
Chemical FormulaC4H7N5O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 11 structure
11
米诺地尔杂质11Minoxidil Impurity 11
Minoxidil Impurity 11
CAS No.128304-91-6
Chemical FormulaC6H10N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 12 structure
12
米诺地尔杂质12Minoxidil Impurity 12
Minoxidil Impurity 12
CAS No.128304-92-7
Chemical FormulaC5H8N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 13 structure
13
米诺地尔杂质13Minoxidil Impurity 13
Minoxidil Impurity 13
CAS No.3270-97-1
Chemical FormulaC5H8N4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 14 structure
14
米诺地尔杂质14Minoxidil Impurity 14
Minoxidil Impurity 14
CAS No.56828-40-1
Chemical FormulaC15H23N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 22 structure
22
米诺地尔杂质22Minoxidil Impurity 22
Minoxidil Impurity 22
CAS No.79459-05-5
Chemical FormulaC9H15N5O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 25 structure
25
米诺地尔杂质25Minoxidil Impurity 25
Minoxidil Impurity 25
CAS No.959054-23-0
Chemical FormulaC4H5ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 26 structure
26
米诺地尔杂质26Minoxidil Impurity 26
Minoxidil Impurity 26
CAS No.131230-62-1
Chemical FormulaC4H6N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 34 structure
34
米诺地尔杂质34Minoxidil Impurity 34
Minoxidil Impurity 34
CAS No.116436-03-4
Chemical FormulaC6H10N4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 35 structure
35
米诺地尔杂质35Minoxidil Impurity 35
Minoxidil Impurity 35
CAS No.156-81-0
Chemical FormulaC4H6N4
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 36 structure
36
米诺地尔杂质36Minoxidil Impurity 36
Minoxidil Impurity 36
CAS No.77940-94-4
Chemical FormulaC12H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 37 structure
37
米诺地尔杂质37Minoxidil Impurity 37
Minoxidil Impurity 37
CAS No.7148-63-2
Chemical FormulaC8H9ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 41 structure
41
米诺地尔杂质41Minoxidil Impurity 41
Minoxidil Impurity 41
CAS No.2889432-05-5
Chemical FormulaC9H14ClN5O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 42 structure
42
米诺地尔杂质42Minoxidil Impurity 42
Minoxidil Impurity 42
CAS No.34960-71-9
Chemical FormulaC4H5ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 44 structure
44
米诺地尔杂质44Minoxidil Impurity 44
Minoxidil Impurity 44
CAS No.114562-80-0
Chemical FormulaC8H15N5
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 47 structure
47
米诺地尔杂质47Minoxidil Impurity 47
Minoxidil Impurity 47
CAS No.35139-68-5
Chemical FormulaC4H4Cl2N4O
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 72 structure
72
米诺地尔杂质72Minoxidil Impurity 72
Minoxidil Impurity 72
CAS No.1350513-60-8
Chemical FormulaC9H14N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 73 structure
73
米诺地尔杂质73Minoxidil Impurity 73
Minoxidil Impurity 73
CAS No.1784008-01-0
Chemical FormulaC9H14ClN5
Purity>95%询价On request
10mg25mg50mg100mg
Minoxidil Impurity 86 structure
86
米诺地尔杂质86Minoxidil Impurity 86
Minoxidil Impurity 86
CAS No.55034-35-0
Chemical FormulaC4H6N4O
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

米诺地尔 —— 研究文献与合成路线Minoxidil — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 米诺地尔 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Minoxidil. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating RP-HPLC method development and validation for the simultaneous determination of aminexil and minoxidil in pharmaceutical dosage form
    Siddiraju S, Sahithi M · Annales pharmaceutiques francaises · 2015 · 被引 1cited 1
  2. Novel quantum dots-based assay for the determination of anti-hypertensive drugs minoxidil and timolol in different matrices
    Ahmed ES, Bahgat EA, Saleh H, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2025 · 被引 1cited 1
  3. Determination of minoxidil in pharmaceutical forms by capillary isotachophoresis
    Fanali S, Cristalli M, Catellani P · Journal of chromatography · 1987 · 被引 6cited 6
  4. Determination of minoxidil in bulk drug and pharmaceutical formulations by ion-pairing high-performance liquid chromatography
    Asmus PA, Landis JB, Grant ME, et al. · Journal of pharmaceutical sciences · 1984 · 被引 4cited 4
  5. Determination of the optimum solvent system for extraction of minoxidil from a tablet dosage form
    Plakogiannis FM, Mahzouf SZ, Babar A · Pharmaceutica acta Helvetiae · 1989 · 被引 2cited 2
  6. Determination of minoxidil in pharmaceutical formulations by difference spectrophotometry and liquid chromatography (HPLC)
    Bonazzi D, Di Pietra AM, Gatti R, et al. · Farmaco (Societa chimica italiana : 1989) · 1990 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. Method for preparing minoxidil tincture
    ZHANG DESHENG · 公开号 CN1961882CN1961882 · 2007
  2. Minoxidil-containing preparations
    IMAMURA KOJI, OCHIAI RUMI, OKAJIMA TAKAKO, MORIOKA SUSUMU, et al. · 公开号 HK1056510HK1056510 · 2007
  3. Minoxidil-containing preparations
    IMAMURA KOJI, OCHIAI RUMI, OKAJIMA TAKAKO, MORIOKA SUSUMU, et al. · 公开号 US2003157046US2003157046 · 2003
  4. Minoxidil-containing preparations
    IMAMURA KOJI, OCHIAI RUMI, OKAJIMA TAKAKO, MORIOKA SUSUMU, et al. · 公开号 ZA200207960ZA200207960 · 2004
  5. Minoxidil-Containing Preparations
    — · 公开号 KR100740393BKR100740393B · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

米诺地尔 杂质谱研究要点Minoxidil — impurity profiling notes

下面这些是拿到 米诺地尔 的 28 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 28 impurity entries for Minoxidil, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances